Maximum residue limits should be set for pharmacologically active substances used or intended to be used in veterinary medicinal products placed on the market in the Community.
Recital 13, Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009…
In forcesince 6 May 2009